Author

Manfredi C. Carta

University of ZurichORCID 0000-0002-0757-3616Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 2 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Adriano AguzziiD· 3 shared Alexandre P. A. TheocharidesiD· 2 shared Karl FrontzekiD· 2 shared Marc EmmeneggeriD· 2 shared Marco LosaiD· 2 shared Simone HornemanniD· 2 shared Veronika LysenkoiD· 2 shared Alessandra Carrella· 1 shared

Activity by Year

2018-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMolecular Biology

Adriano AguzziORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

NeuroscienceCell ReportsPeer-reviewedJun 1, 2021

An integrated genomic approach to dissect the genetic landscape regulating the cell-to-cell transfer of a-synuclein

Eleanna Kara, Alessandro Crimi, Anne E. Wiedmer…·Adriano Aguzzi

The paper identifies 38 genes regulating a-synuclein cell-to-cell transfer using an siRNA screen and shows genetic overlap with Parkinson's disease.

13 citations

humanstatistical model

Molecular BiologybioRxivPreprintMay 1, 2021

The ASC inflammasome adapter controls the extent of peripheral protein aggregate deposition in inflammation-associated amyloidosis

Marco Losa, Marc Emmenegger, Pierre De Rossi…·Adriano Aguzzi

This paper shows that ASC controls AA amyloidosis by interacting with SAA and that anti-ASC antibodies reduce amyloid loads in mice.

2 citations

Molecular BiologyPLoS PathogensPeer-reviewedOct 1, 2018

A bispecific immunotweezer prevents soluble PrP oligomers and abolishes prion toxicity

Marco Bardelli, Karl Frontzek, Luca Simonelli…·Luca Varani

This paper introduces a bispecific antibody that targets both the globular domain and flexible tail of PrP, preventing prion toxicity and oligomer formation.

22 citations

mouseexperimental assay